A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

NCT06847464 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection
Drug Drug Interaction (DDI)

Interventions

DRUG: EDP-323
DRUG: Itraconazole
DRUG: EDP-323
DRUG: carbamazepine
DRUG: EDP-323
DRUG: Quinidine
DRUG: EDP-323
DRUG: fluconazole

Sponsor

Enanta Pharmaceuticals, Inc